262 results
P
acute basilar artery occlusion, bilateral vertebral artery occlusion
I/C
endovascular therapy, best medical management, best medical management
O
ambulation, independence, mortality, symptomatic intracranial hemorrhage
P
Presbyopia patients with bilateral cataracts
I/C
Trifocal intraocular lens (IOL), Bifocal IOL
O
Uncorrected distance visual acuity, uncorrected near visual acuity, uncorrected intermediate visual acuity, best-corrected visual acuity, contrast sensitivity, quality of life
P
COVID-19, AI, IoT
I/C
diagnosis, tracking, prediction, ML-based techniques
O
best performances
P
influenza antiviral drugs
I/C
efficacy/effectiveness, current best SR practices
O
critically low quality
P
ALL, NHL
I/C
CD22 CAR T-cells, CD19/CD22 CAR T-cells, anti-CD19 CAR T-cells
O
best complete response (bCR)
P
central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO)
I/C
intravitreal anti-vascular endothelial growth factor (anti-VEGF), anti-VEGF monotherapy
O
best-corrected visual acuity (BCVA)
P
IgE-mediated food allergy, omalizumab, cow's milk allergy
I/C
biological therapy, monotherapy, adjunct to oral immunotherapy, speculation
O
personalized treatment, best candidate for each treatment, optimal dose and timing
P
patients with advanced hepatocellular carcinoma (HCC)
I/C
combination therapy with immune checkpoint inhibitors (ICIs) and best combination regimen, monotherapy with PD-1/PD-L1 inhibitors and sorafenib
O
overall response rate (ORR), disease control rate (DCR), progression-free survival (PFS), overall survival (OS)
P
Fuchs corneal endothelial dystrophy patients
I/C
Descemet stripping only (DSO) + Rho-kinase inhibitors (ROC-i), Observation group
O
Corneal clearance, time to corneal clearance, postoperative endothelial cell count (ECC), best-corrected visual acuity (BCVA)
P
patients with staged implant-based breast reconstruction (IBR)
I/C
fat grafting during second-stage expander/implant exchange, third-stage fat grafting
O
BREAST-Q satisfaction with outcome scores